- ACRX has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $22.1 million.
- ACRX has traded 558,548 shares today.
- ACRX is down 3% today.
- ACRX was up 6.7% yesterday.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in ACRX with the Ticky from Trade-Ideas. See the FREE profile for ACRX NOW at Trade-Ideas More details on ACRX: AcelRx Pharmaceuticals, Inc., a development stage specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute and breakthrough pain (BTP). Currently there are 4 analysts that rate AcelRx Pharmaceuticals a buy, no analysts rate it a sell, and 2 rate it a hold. The average volume for AcelRx Pharmaceuticals has been 1.1 million shares per day over the past 30 days. AcelRx has a market cap of $282.8 million and is part of the health care sector and health services industry. The stock has a beta of 1.84 and a short float of 24.4% with 2.39 days to cover. Shares are down 38.5% year-to-date as of the close of trading on Thursday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.